Premium Company Profile: Daimler AG

Premium Company Profile: Daimler AG

Introduction

Daimler AG, formerly DaimlerChrysler AG*, is a supplier of passenger cars, and commercial vehicles. The company aims to achieve sustainable profitable growth through the development superior products, and customer-relevant technologies.

Scope

Contains corporate strategy, value chain presence and SWOT Analysis Provides detailed business description, segment analysis, 5-year financial trends, key products and key competitors Includes information on suppliers/ partners, shareholding structure and key employees with biographies

Highlights

Daimler AG is the parent company of the Daimler Group. The group develops, manufactures, distributes and sells automotive products, mainly passenger cars, trucks, vans and buses. The group also provides financial and other services related to its automotive businesses. The group primarily operates in Americas and Western Europe. The group has 100 manufacturing facilities all over the world, of which 19 are located in Germany and 35 are in the US. Most of the remaining facilities are in Brazil, Canada, France, Japan, Mexico, South Africa, Spain and Turkey. The company has recorded strong profit during the last year. The company recorded an operating profit of E3,377 million during fiscal year 2006, an increase of 4.8% over 2005. The net profit was E3,227 million in fiscal year 2006, an increase of 13.4% over 2005.

Reasons to Purchase

Access all the important information and analysis on the company in a single report Understand company's strengths, weaknesses, opportunities and threats along with business strategy and value chain Gain access to company's adjusted five year financial data along with key ratios and market capitalization.

THIS MONTH'S HIGHLIGHTS 2
Research & Development 5
Research Update 7
Results Update 8
Regulatory 11
Applications Update 11
Mergers & Acquisitions Update 19
COMPANY SPOTLIGHT – Medarex 21
Key Facts 24
Major Products & Services 24
FURTHER READING 26
Latest reports 26
INDEX 27
Pharma Companies 27
Biotech Companies 27